RLAY financials
Relay Therapeutics (RLAY) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RLAY income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $15.36M | $11.80M | -$302.74M | -$276.48M | -1.61 |
| 2024 | $10.01M | -$305.43M | -$372.47M | -$337.71M | -2.36 |
| 2023 | $25.55M | -$300.84M | -$373.00M | -$341.97M | -2.79 |
| 2022 | $1.38M | -$241.62M | -$299.27M | -$290.51M | -2.59 |
| 2021 | $3.03M | -$166.36M | -$364.70M | -$363.87M | -3.82 |
| 2020 | $82.65M | $79.11M | -$55.80M | -$52.41M | -2.56 |
- RLAY revenue was $15.36M in fiscal 2025, net income -$276.48M.
Updated 2026-11-07 11:55 UTC